Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 83 (2) , 404-411
Abstract
No abstract availableKeywords
Funding Information
- American Society of Hematology
This publication has 12 references indexed in Scilit:
- Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ SubtypeAmerican Journal of Clinical Dermatology, 2015
- Subsequent cancers, mortality, and causes of death in patients with mycosis fungoides and parapsoriasis: A Danish nationwide, population-based cohort studyJournal of the American Academy of Dermatology, 2014
- Outcomes After Diagnosis of Mycosis Fungoides and Sézary Syndrome Before 30 Years of AgeJAMA Dermatology, 2014
- Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry studyBMC Cancer, 2014
- Second Lymphomas and Other Malignant Neoplasms in Patients With Mycosis Fungoides and Sézary SyndromeArchives of Dermatology, 2007
- Immunopathogenesis and therapy of cutaneous T cell lymphoma.2005
- Increased Risk of Secondary Cancers in Patients with Primary Cutaneous T Cell LymphomaJournal of Investigative Dermatology, 2000
- Risk of second malignancy after cutaneous T-cell lymphomaCancer, 1989
- Logistic Regression, Survival Analysis, and the Kaplan-Meier CurveJournal of the American Statistical Association, 1988
- Multivariate Generalizations of the Proportional Hazards ModelJournal of the Royal Statistical Society. Series A (General), 1985